MedPath

To compare amh levels between women receiving intra ovarian platelet rich plasma injection to those receiving intra ovarian saline injection in women with infertility due to primary ovarian failure

Phase 3
Conditions
Health Condition 1: X- New Technology
Registration Number
CTRI/2024/06/069310
Lead Sponsor
Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

anti mullerian hormone less than 1.1ng/dl

patient willing to undergo laparoscopy hysteroscopy fertility enhancing surgery and willing to consent

Exclusion Criteria

active pelvic inflammatory disease

abnormal ovary on USG

known platelet or thromboxane synthesis disorder/abnormal coagulation profile

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath